(VIANEWS) – IBA (IBAB.BR), ABC ARBITRAGE (ABCA.PA), MELEXIS (MELE.BR) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. IBA (IBAB.BR)
140.29% Payout Ratio
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €1.42.
PE Ratio
IBA has a trailing twelve months price to earnings ratio of 11.74. Meaning, the purchaser of the share is investing €11.74 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.68%.
Volume
Today’s last reported volume for IBA is 10464 which is 20.2% below its average volume of 13113.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 335.81M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 29, 2022, the estimated forward annual dividend rate is 0.19 and the estimated forward annual dividend yield is 1.05%.
Moving Average
IBA’s worth is below its 50-day moving average of €17.50 and higher than its 200-day moving average of €15.83.
2. ABC ARBITRAGE (ABCA.PA)
128.89% Payout Ratio
ABC arbitrage SA, together with its subsidiaries, develops arbitrage strategies for liquid assets worldwide. It develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. The company was incorporated in 1995 and is based in Paris, France.
Earnings Per Share
As for profitability, ABC ARBITRAGE has a trailing twelve months EPS of €0.6.
PE Ratio
ABC ARBITRAGE has a trailing twelve months price to earnings ratio of 10.4. Meaning, the purchaser of the share is investing €10.4 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.35%.
3. MELEXIS (MELE.BR)
53.28% Payout Ratio
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN/CAN system basis, NFC/RFID, radio-frequency receiver and transmitter, and switch controller ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Earnings Per Share
As for profitability, MELEXIS has a trailing twelve months EPS of €1.89.
PE Ratio
MELEXIS has a trailing twelve months price to earnings ratio of 54.12. Meaning, the purchaser of the share is investing €54.12 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.26%.
Sales Growth
MELEXIS’s sales growth is 22.9% for the ongoing quarter and 18.6% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 3.3% and positive 6.8% for the next.
4. MERCK AND CO INC (MRK.PA)
49.04% Payout Ratio
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Earnings Per Share
As for profitability, MERCK AND CO INC has a trailing twelve months EPS of €2.3.
PE Ratio
MERCK AND CO INC has a trailing twelve months price to earnings ratio of 43.82. Meaning, the purchaser of the share is investing €43.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.46%.
5. GLANBIA PLC (GL9.IR)
42.45% Payout Ratio
Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Earnings Per Share
As for profitability, GLANBIA PLC has a trailing twelve months EPS of €0.49.
PE Ratio
GLANBIA PLC has a trailing twelve months price to earnings ratio of 27.61. Meaning, the purchaser of the share is investing €27.61 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.06%.
6. PAREF (PAR.PA)
33.79% Payout Ratio
Paref SA owns and manages business real estate located primarily in the Paris region. The company manages and leases real estate, offices and commercial spaces, and residences. The company also provides real estate agency services. The company was founded in 1997 and is based in Paris, France.
Earnings Per Share
As for profitability, PAREF has a trailing twelve months EPS of €13.46.
PE Ratio
PAREF has a trailing twelve months price to earnings ratio of 4.53. Meaning, the purchaser of the share is investing €4.53 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.78%.
Moving Average
PAREF’s value is way below its 50-day moving average of €68.08 and below its 200-day moving average of €62.47.
